Why psychiatry needs better patient outcome data on medical cannabis
Dr Imogen Kretzschmar, consultant psychiatrist at Mamedica, examines medical cannabis's mental health benefits for patients under specialist supervision. Dr Imogen…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Hyperfine’s portable MRI system demonstrates time-saving benefit in new data readout
Hyperfine has shared new data demonstrating time-saving advantages for its portable brain MRI system’s integration into emergency department workflows versus…
-
Site success in clinical trials begins with financial certainty
Carolina Carrasco, senior director at IQVIA, explores how fragmented financial workflows can create administrative burden and uncertainty for trial sites.…
-
Jupiter Endovascular’s pulmonary embolectomy system hits primary endpoints in trial
Jupiter Endovascular has shared positive pivotal trial results for its Vertex pulmonary embolectomy system in treating pulmonary embolism (PE). The…
-
What happens when protocol data finally flows
Rob DiCicco, vice president of portfolio management, and Bill Illis, workstream leader, digital data flow at TransCelerate BioPharma, highlight the advantages of…
-
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial
Boston Scientific has shared positive pivotal trial results for its SEISMIQ 4CE Coronary intravascular lithotripsy (IVL) catheter in treating calcified…
-
UK health secretary Wes Streeting resigns
UK health secretary Wes Streeting has resigned, citing a ‘loss of faith’ in the Labour party’s leadership under Prime Minister…
-
Why single biomarkers are no longer enough: a new paradigm in colorectal cancer
In colorectal cancer (CRC), biomarkers have long been used to decide if patients are eligible for a particular therapy or…
-
500,000 patients’ data for sale online after UK Biobank breach
Last week, data from 500,000 participants of UK Biobank’s database were made available for sale online following a breach, the…
-
Xeltis gains EU CE mark on positive trial data for vascular access graft
Xeltis has gained a European CE mark for aXess, with 12-month pivotal data of the vascular access graft for haemodialysis…